Skip to main content
Top

Current Breast Cancer Reports

Issue 3/2016

Content (6 Articles)

Open Access Clinical Trials (S Hurvitz, Section Editor)

Reducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and Exercise

Christina M. Dieli-Conwright, Kyuwan Lee, Jacqueline L. Kiwata

Clinical Trials (S Hurvitz, Section Editor)

Screening for Cognitive Impairment Associated with Chemotherapy for Breast Cancer

Diane F. Morean, Leora R. Cherney

Open Access Risk and Prevention (TB Bevers, Section Editor)

Physician and Patient Barriers to Breast Cancer Preventive Therapy

Susan Hum, Melinda Wu, Sandhya Pruthi, Ruth Heisey

Risk and Prevention (TB Bevers Section Editor)

Current Approach to Breast Cancer Risk Reduction for Women with Hereditary Predispositions to Breast Cancer

Grace Tran, Monica Helm, Jennifer Litton

Risk and Prevention (TB Bevers, Section Editor)

Update on Breast Cancer Risk Reduction Therapy

Victor G. Vogel

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine